Community Cancer Centers Pilot Patient Survey
NCT00786656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3955
Last updated 2019-12-17
Summary
Background:
* Studies suggest that cancer patients diagnosed and treated in a facility with multi-specialty care and clinical research may live longer and have a better quality of life than patients treated elsewhere.
* The NCI Community Cancer Centers Pilot Program (NCCCP) is a 3-year program to test the concept of a national network of community cancer centers to expand cancer research and deliver the most advanced cancer care to Americans in their own communities.
* The pilot program includes a survey of cancer patients receiving care at the pilot sites.
Objectives:
* To gain an understanding of the experiences of adult patients who receive services at the NCCCP pilot sites and assess if and how their experience changes over the study period. Data about the following are collected:
* Patients information needs and awareness of the NCCCP program
* Clinical trials experience
* Access to health care
* Perspectives on patient-provider communication
* Experiences with patient navigation, self-management, medical decision-making and survivorship
* Satisfaction with care and quality of life
Eligibility:
* Patients 21 years or older at the time of diagnosis
* Treatment at the cancer center for at least 3 months since July 1, 2007
Design:
* Participants complete a 25-minute questionnaire covering the care they received at their cancer center, their experience with making medical appointments and how long they waited to see the doctor. The survey includes information on the following:
* Services at the cancer center
* Getting needed care
* Assistance for patients and their families
* Communication with the cancer care team
* Clinical trials
* Care after finishing treatment
* Evaluation of care
* Health and medical history
* Background information (demographics)
Conditions
- Malignant Neoplasms
- Cancer
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Irene P Prabhu Das, Ph.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 21 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-11-03
- Completion
- 2015-05-11
Countries
- United States
Study Locations
More Related Trials
-
NCI COVID-19 in Cancer Patients, NCCAPS Study
NCT04387656 ·Status: ACTIVE_NOT_RECRUITING
-
An Investigation of Small Intestinal Carcinoid Carcinoma in Families
NCT00662168 ·Status: UNKNOWN
-
Registry Study for Personalized Cancer Therapy
NCT02508662 ·Status: COMPLETED
-
Omics of Cancer: OncoGenomics
NCT05431439 ·Status: WITHDRAWN
-
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001938 ·Status: COMPLETED
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
NCT06877884 ·Status: RECRUITING
-
Circulating Tumor Cells in Solid Tumors
NCT03161821 ·Status: COMPLETED
-
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585 ·Status: COMPLETED
-
Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment
NCT07306338 ·Status: RECRUITING
-
Role of Gut Microbiome in Cancer Therapy
NCT05112614 ·Status: RECRUITING
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Tissue Samples for Study of Multidrug Resistance
NCT00880503 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Morehouse Total Cancer Care Protocol
NCT04804878 ·Status: RECRUITING
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045 ·Status: TERMINATED
-
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT02810405 ·Status: COMPLETED
-
Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer
NCT05541874 ·Status: NOT_YET_RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT01109394 ·Status: RECRUITING
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Collection of Tissue Samples for Cancer Research
NCT00900198 ·Status: RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
NCT02781025 ·Status: COMPLETED
-
A Study of Risk Factors for the COVID-19 Virus Infection
NCT04697927 ·Status: ACTIVE_NOT_RECRUITING